135 related articles for article (PubMed ID: 28771681)
1. Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients.
Leoncini PP; Vitullo P; Di Florio F; Tocco V; Cefalo MG; Pitisci A; Girardi K; Niemeyer C; Locatelli F; Bertaina A
Br J Haematol; 2018 Sep; 182(6):909-912. PubMed ID: 28771681
[No Abstract] [Full Text] [Related]
2. Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.
Flotho C
Epigenetics; 2019 Mar; 14(3):236-244. PubMed ID: 30773984
[TBL] [Abstract][Full Text] [Related]
3. Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7.
Furlan I; Batz C; Flotho C; Mohr B; Lübbert M; Suttorp M; Niemeyer CM
Blood; 2009 Mar; 113(12):2867-8. PubMed ID: 19299654
[No Abstract] [Full Text] [Related]
4. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.
Schönung M; Meyer J; Nöllke P; Olshen AB; Hartmann M; Murakami N; Wakamatsu M; Okuno Y; Plass C; Loh ML; Niemeyer CM; Muramatsu H; Flotho C; Stieglitz E; Lipka DB
Clin Cancer Res; 2021 Jan; 27(1):158-168. PubMed ID: 33139265
[TBL] [Abstract][Full Text] [Related]
5. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
Fluhr S; Boerries M; Busch H; Symeonidi A; Witte T; Lipka DB; Mücke O; Nöllke P; Krombholz CF; Niemeyer CM; Plass C; Flotho C
Clin Epigenetics; 2016; 8():50. PubMed ID: 27158276
[TBL] [Abstract][Full Text] [Related]
6. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Niemeyer CM; Flotho C; Lipka DB; Starý J; Rössig C; Baruchel A; Klingebiel T; Micalizzi C; Michel G; Nysom K; Rives S; Schmugge Liner M; Zecca M; Schönung M; Baumann I; Nöllke P; Benettaib B; Biserna N; Poon J; Simcock M; Patturajan M; Menezes D; Gaudy A; van den Heuvel-Eibrink MM; Locatelli F
Blood Adv; 2021 Jul; 5(14):2901-2908. PubMed ID: 34297046
[TBL] [Abstract][Full Text] [Related]
7. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Flotho C; Sommer S; Lübbert M
Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
Olk-Batz C; Poetsch AR; Nöllke P; Claus R; Zucknick M; Sandrock I; Witte T; Strahm B; Hasle H; Zecca M; Stary J; Bergstraesser E; De Moerloose B; Trebo M; van den Heuvel-Eibrink MM; Wojcik D; Locatelli F; Plass C; Niemeyer CM; Flotho C;
Blood; 2011 May; 117(18):4871-80. PubMed ID: 21406719
[TBL] [Abstract][Full Text] [Related]
9. Panobinostat inhibits the proliferation of CD34
Kurata T; Matsuda K; Hirabayashi K; Shigemura T; Sakashita K; Nakahata T; Koike K
Pediatr Blood Cancer; 2018 Nov; 65(11):e27261. PubMed ID: 30014555
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.
Locatelli F; Algeri M; Merli P; Strocchio L
Expert Rev Hematol; 2018 Feb; 11(2):129-143. PubMed ID: 29279013
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.
Wilhelm T; Lipka DB; Witte T; Wierzbinska JA; Fluhr S; Helf M; Mücke O; Claus R; Konermann C; Nöllke P; Niemeyer CM; Flotho C; Plass C
Epigenetics; 2016; 11(2):110-9. PubMed ID: 26891149
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.
Stieglitz E; Mazor T; Olshen AB; Geng H; Gelston LC; Akutagawa J; Lipka DB; Plass C; Flotho C; Chehab FF; Braun BS; Costello JF; Loh ML
Nat Commun; 2017 Dec; 8(1):2127. PubMed ID: 29259179
[TBL] [Abstract][Full Text] [Related]
13. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.
Hashmi SK; Punia JN; Marcogliese AN; Gaikwad AS; Fisher KE; Roy A; Rao P; Lopez-Terrada DH; Ringrose J; Loh ML; Niemeyer CM; Rau RE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27905. PubMed ID: 31250550
[TBL] [Abstract][Full Text] [Related]
14. Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
Hecht A; Meyer J; Chehab FF; White KL; Magruder K; Dvorak CC; Loh ML; Stieglitz E
Pediatr Blood Cancer; 2019 Nov; 66(11):e27948. PubMed ID: 31347788
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
Honda Y; Muramatsu H; Nanjo Y; Hirabayashi S; Meguro T; Yoshida N; Kakuda H; Ozono S; Wakamatsu M; Moritake H; Yasui M; Sano H; Manabe A; Sakashita K
Int J Hematol; 2022 Feb; 115(2):263-268. PubMed ID: 34714526
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the PTEN gene CpG island is infrequent in juvenile myelomonocytic leukemia: Comments on "PTEN deficiency is a common defect in juvenile myelomonocytic leukemia" [Leuk. Res. 2009;33:671-677 (Epub 2008 November 17)].
Batz C; Sandrock I; Niemeyer CM; Flotho C
Leuk Res; 2009 Nov; 33(11):1578-9; author reply 1580. PubMed ID: 19487024
[No Abstract] [Full Text] [Related]
17. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia.
Nakazawa Y; Matsuda K; Kurata T; Sueki A; Tanaka M; Sakashita K; Imai C; Wilson MH; Koike K
J Hematol Oncol; 2016 Mar; 9():27. PubMed ID: 26983639
[TBL] [Abstract][Full Text] [Related]
18. BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia.
Wu Y; Zehnle PMA; Rajak J; Koleci N; Andrieux G; Gallego-Villar L; Aumann K; Boerries M; Niemeyer CM; Flotho C; Bohler S; Erlacher M
Leukemia; 2024 Jan; 38(1):136-148. PubMed ID: 37945692
[TBL] [Abstract][Full Text] [Related]
19. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.
Cseh A; Niemeyer CM; Yoshimi A; Dworzak M; Hasle H; van den Heuvel-Eibrink MM; Locatelli F; Masetti R; Schmugge M; Groß-Wieltsch U; Candás A; Kulozik AE; Olcay L; Suttorp M; Furlan I; Strahm B; Flotho C
Blood; 2015 Apr; 125(14):2311-3. PubMed ID: 25838281
[No Abstract] [Full Text] [Related]
20. [Not Available].
Oliveira AF; Tansini A; Toledo T; Balceiro R; Lee MLM; Villela N; Ikeuty P; Metze K; Lopes LF; Lorand-Metze I
Br J Haematol; 2022 May; 197(3):339-348. PubMed ID: 35187646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
